Antimalarial ligands

ACT-451840.

AIM-1290.

AIM-1290.

albitiazolium.

albitiazolium.

InformationAltiratinib (DCC-2701) is a potent single-digit nanomolar inhibitor ofTRK, Met (c-Met), TIE2, and VEGFR2 kinaseswith IC50 vaules of 0.9 nM, 4.6 nM, and 0.8 nM for TRKA, B, and C, respectively. It inhibits Met (c-Met) and Met (c-Met)

InformationAltiratinib (DCC-2701) is a potent single-digit nanomolar inhibitor ofTRK, Met (c-Met), TIE2, and VEGFR2 kinaseswith IC50 vaules of 0.9 nM, 4.6 nM, and 0.8 nM for TRKA, B, and C, respectively. It inhibits Met (c-Met) and Met (c-Met)

InformationAltiratinib (DCC-2701) is a potent single-digit nanomolar inhibitor ofTRK, Met (c-Met), TIE2, and VEGFR2 kinaseswith IC50 vaules of 0.9 nM, 4.6 nM, and 0.8 nM for TRKA, B, and C, respectively. It inhibits Met (c-Met) and Met (c-Met)

Amodiaquine is both anti-malarial and anti-inflammatory.

Amodiaquine is both anti-malarial and anti-inflammatory.

Amodiaquine is both anti-malarial and anti-inflammatory.

Amodiaquine is both anti-malarial and anti-inflammatory.